- Home
- ML vs SPRY Comparison
ML vs SPRY Comparison
Compare ML & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ML
- SPRY
- Stock Information
- Founded
- ML 2013
- SPRY 2015
- Country
- ML United States
- SPRY United States
- Employees
- ML N/A
- SPRY N/A
- Industry
- ML Retail: Computer Software & Peripheral Equipment
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- ML Technology
- SPRY Health Care
- Exchange
- ML Nasdaq
- SPRY Nasdaq
- Market Cap
- ML 970.3M
- SPRY 1.1B
- IPO Year
- ML N/A
- SPRY N/A
- Fundamental
- Price
- ML $86.73
- SPRY $12.57
- Analyst Decision
- ML Buy
- SPRY Strong Buy
- Analyst Count
- ML 7
- SPRY 4
- Target Price
- ML $100.00
- SPRY $26.00
- AVG Volume (30 Days)
- ML 186.8K
- SPRY 1.5M
- Earning Date
- ML 03-06-2025
- SPRY 11-13-2024
- Dividend Yield
- ML N/A
- SPRY N/A
- EPS Growth
- ML N/A
- SPRY N/A
- EPS
- ML 0.28
- SPRY N/A
- Revenue
- ML $500,281,000.00
- SPRY $2,568,000.00
- Revenue This Year
- ML $30.87
- SPRY $66,750.00
- Revenue Next Year
- ML $23.59
- SPRY $508.63
- P/E Ratio
- ML $301.94
- SPRY N/A
- Revenue Growth
- ML 23.40
- SPRY 8460.00
- 52 Week Low
- ML $36.65
- SPRY $6.00
- 52 Week High
- ML $106.82
- SPRY $18.51
- Technical
- Relative Strength Index (RSI)
- ML 56.70
- SPRY 58.86
- Support Level
- ML $85.23
- SPRY $11.00
- Resistance Level
- ML $86.81
- SPRY $12.48
- Average True Range (ATR)
- ML 1.17
- SPRY 0.81
- MACD
- ML -0.49
- SPRY 0.28
- Stochastic Oscillator
- ML 55.15
- SPRY 84.95
About ML MoneyLion Inc.
MoneyLion Inc is a mobile banking and financial membership platform that empowers people to take control of their finances. It is a full-service digital platform to deliver mobile banking, lending, and investment solutions. The company offers a personalized, all-in-one, digital financial platform that provides convenient, low-cost access to banking, borrowing, and investing solutions tailored for its customers, rooted in data, and delivered through its proprietary technology platform.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.